Search filters

List of works by Young-Kwang Yoon

Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells ⬇️

scientific article published on March 1, 2012

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer ⬇️

scientific article published on March 28, 2011

Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer ⬇️

scientific article published on November 9, 2012

Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells

scientific article published on 15 September 2009

Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells

scientific article

Expedited Safety Reporting to Sponsors Through the Implementation of an Alert System for Clinical Trial Management at an Academic Medical Center: Retrospective Design Study

scientific article published on 23 February 2020

Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center

scientific article published on 12 August 2019

Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers

scientific article

Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody ⬇️

scientific article published on March 16, 2012

KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approach

scientific article published on April 2010

Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2.

scientific article

RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase ⬇️

scientific article published on August 19, 2010

RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib ⬇️

scientific article published on March 19, 2013

Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer ⬇️

scientific article published on January 20, 2012

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines

scientific article published on 6 September 2008

The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines ⬇️

scientific article published on December 25, 2011

Paulina is supported by:

About Paulina

Help